ProTom International Signed a Strategic Distribution and Lic

ProTom International Signed a Strategic Distribution and Licensing Agreement to Distribute with GHGK in China
News provided by
Share this article
Share this article
WAKEFIELD, Mass., Jan. 11, 2021 /PRNewswire/ -- ProTom International Holding Corporation ("ProTom") is pleased to announce that it has signed a distribution and licensing agreement with Guohong Guokang (Beijing) Health Technology Development Co., LTD ("GHGK") who, along with its affiliates, is one of the leading comprehensive high-tech innovative enterprises in China for an exclusive distribution and licensing Agreement to distribute ProTom's Radiance 330® Proton Therapy System in mainland China. The signing of this agreement marks an important milestone for improving the clinical outcomes of cancer patients in China and the

Related Keywords

China , United States , Stephen Spotts , Protom International , Protom International Holding Corporation , Guohong Guokang Beijing Health Technology Development Co , Sino Hope Group , Office Of Protom International , Guohong Guokang , Proton Therapy System , Chief Executive Office , Licensing Agreement , Chairman Zhang , Tom International Holding Corporation , Therapy System , சீனா , ஒன்றுபட்டது மாநிலங்களில் , ஸ்டீபன் புள்ளிகள் , சினோ நம்பிக்கை குழு , ப்ரோடாந் சிகிச்சை அமைப்பு , தலைமை நிர்வாகி அலுவலகம் , தலைவர் ஜாங் , டோம் சர்வதேச வைத்திருத்தல் நிறுவனம் , சிகிச்சை அமைப்பு ,